Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
BMC Cancer|March 15, 2018
A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case reportYing Pang, Garima Gupta, Chunzhang Yang, et al.
The International Journal of Neuroscience|November 6, 2020
Remodeling of occluded internal carotid artery in vessel wall magnetic resonance imagingJun Zhou, Shi-Feng Cai, Xian-Shun Yuan, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|December 11, 2007
[A novel mutation in the myocilin gene identified in a Chinese primary open angle glaucoma family]Qiang Tian, Fu-hua Li, Kan-xing Zhao, et al.
Nanomedicine (London, England)|January 24, 2024
Heating tumors with tumor cell-derived nanoparticles to enhance chemoimmunotherapy for colorectal cancerXin-Ying Li, Rong-Hui Li, Jun-Zi Cong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and ParagangliomaYing Pang, Yanxin Lu, Veronika Caisova, et al.
Psycho-Oncology|March 30, 2022
Prevalence of DSM-5 somatic symptom disorder in Chinese patients with breast cancerJinjiang Li, Kurt Fritzsche, Mark Glinka, et al.
Journal of Neurotrauma|August 29, 2025
Clostridium butyricum Restores Intestinal Barrier Integrity via the IL-22/Reg3 Pathway Following Traumatic Brain Injury in MiceMin Liu, Ying Pang, Li Xu, et al.
Neoplasia (New York, N.Y.)|February 7, 2026
OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancerDan Wei, Jiang Chen, Feihu Bai, et al.
Cancer Letters|March 25, 2026
YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastomaMeng Cheng, Ying Pang, Rui Wang, et al.
BMJ Open|January 14, 2021
Longitudinal study of symptom burden in outpatients with advanced cancers based on electronic Patient-Reported Outcome (ePRO) platform: a single institution, prospective study protocolLili Tang, Ying Pang, Yi He, et al.
Pageof 23